Measles Vaccines

//Measles Vaccines
­

Adverse Reactions

In 1981, the British National Childhood Encephalopathy Study concluded that there was a statistically significant association between measles vaccination and the onset of a serious neurological disorder within 14 days of receiving measles vaccine. But measles vaccination has been shown by medical authorities to also cause anaphylaxis, angioneurotic edema, ataxia, bronchial spasms, deafness, dizziness, encephalitis, erythema multiforme, febrile and afebrile convulsions, fever, Guillain Barre syndrome, headache, leukocytosis, ocular palsies, optic neuritis, otitis media, pannicultitis, pneumonitis, retinitis, rash, seizures, Stevens-Johnsons syndrome, subacute sclerosing panencephalitis, urticaria, and death.

New Disease Created

An atypical, very severe form of measles (called Atypical Measles) occurs when the measles vaccine virus infects the injected person. Symptoms begin with a fever, headache and stomach pain for several days and then a rash appears on the hands and feet and progresses towards the head – just the opposite progression that is seen in natural measles. Severe pneumonia is a common complication and can end in death.

Long-Term Adverse Effects

In 1995, a British study concluded that adults who were vaccinated with measles vaccine as children were at much higher risk of developing inflammatory bowel disease such as Crohn’s disease and ulcerative colitis, as adults. But we have no way of validating other long term effects because no safety studies have ever been performed to license a measles vaccine. (1)

Measles Pushes the Disease into High Risk Groups

Before 1963 (introduction of measles vaccine) infants under one year of age were extremely unlikely to contract measles because their mother had developed life-long immunity from natural measles and conferred antibodies to their infant. By 1992, over 28% of measles cases occurred in infants, when they’re most at risk of complications. (2)

Inadequate Safety Studies

The manufacturer has warned that the measles vaccine “has not been evaluated for carcinogenicity or mutagenic potential” and “it s not known whether (the measles vaccine) can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. The vaccine strain of the virus is … capable of inducing adverse fetal effects.. Caution should be exercised when … administered to a nursing woman ” (1) WAVE asks: How does one cautiously administer a vaccine?

References:

  1. Physicians Desk reference (PDR); 55th edition (Montvale, NJ: Medical Economics. 2001) p 1884
  2. CDC. Cited in Haney, D.Q. “Wave of infant measles stems from ’60’s vaccinations.” Albuquerque Journal (November 23, 1992), p B3

Long-Term Adverse Effects

In 1995, a British study concluded that adults who were vaccinated with measles vaccine as children were at much higher risk of developing inflammatory bowel disease such as Crohn’s disease and ulcerative colitis, as adults. But we have no way of validating other long term effects because no safety studies have ever been performed to license a measles vaccine.

Inadequate safety studies

The manufacturer has warned that the measles vaccine

Measles is a benign disease

Before the 1960’s most children contracted common measles in the US. Complications were very rare and usually self-limiting. A vaccine is unnecessary.

Measles was already on the Decline

Vaccination had nothing to do with the continued decline in the incidence of measles in the US. From 1958 to 1962, a year before the measles vaccine was introduced, the number of cases had already fallen 38%. More generally, the death rate from measles in United States and Great Britain had fallen by 98% from 1915 to 1958. (1)

Epidemics Regularly Occur in Highly Vaccinated Population

Large outbreaks often have showed that over 95% were previously vaccinated with measles.(2) View the documentation on this page. The medical literature is replete with evidence of measles vaccine failures.

References:

  1.  Alderson, M International Mortality Statistics (Washington, DC Facts on File., 1981) pp. 182-183
  2. FDA. “FDA workshop to review warnings, use instructions, and precautionary information (on vaccines).” (Rockland, Maryland: FDA, September 18, 1992, p 27.

 

Measles Vaccines by Brand

Attenuvax® Measles Virus Vaccine Live
Manufacturer Merck & Co.
Microorganism The Rubeola virus
Licensed 01/31/2007
Recommendations 2 injections given at 12 to 15 months of age, and at four to six years of age. Even if previously received the monovalent measles vaccine.
Ingredients Gelatin, Neomycin, Sorbitol, Sucrose, Sodium chloride, Bovine (cow) serum, Sodium phosphate, Virus: Measles, Egg protein, Human albumin
Product Descriptions Vaccine safety

DIPLOVAX HDC 4.0 Freeze-dried measles vaccine
Manufacturer Biovac
Microorganism Measles
Licensed Y/30.1/246 (reg. number)
Recommendations Single 0.5 mL s.c. injection for children age 9 months with a booster at 18 months.
Ingredients Gelatin, Human Diploid cells: MRC5 proteins, Sorbitol, Virus: Measles
Product Descriptions http://whale.to/v/diplovax.html

M-M-Vax Measles and Mumps Virus Vaccine Live
Manufacturer Merck
Microorganism Measles, Mumps
Licensed 06/02/1998
Recommendations 12 months or older, single dose.
Ingredients Gelatin, Neomycin, Sorbitol, Sodium chloride, Bovine (cow) serum, Sodium phosphate, Virus: Measles, Virus: Mumps, Human albumin
Product Descriptions Package insert

M-M-RVAXPRO Measles, mumps, and rubella vaccine (live)
Manufacturer Merck Sharp & Dohme B.V.
Microorganism Measles, Mumps, Rubella
Licensed 05/05/2006
Recommendations Individuals 12 months or older should receive one injection. A second injection may be given at least 4 weeks after the first. The second is intended for peoples who did not respond to the first injection for any reason. There is no information on the safety and effectiveness of this product on infants below 12 months.
Ingredients Gelatin, Monosodium Glutamate (MSG), Neomycin, Phenol, Sorbitol, Sodium bicarbonate, Sucrose, Sodium phosphate, Sodium hydroxide, Hydrochloric acid, Medium 199, Potassium phosphate, Virus: Measles, Virus: Mumps, Virus: Rubella, Minimum Essential Medium
Product Descriptions

M-R VAX, M-R-VAX II Measles and Rubella Virus Vaccine Live
Manufacturer Merck
Microorganism Measles, Rubella (live)
Licensed 04/22/1971
Recommendations One i.m. injection (0.5 mL) for adults and children 12 months of age and older.
Ingredients Gelatin, Human Diploid cells: MRC5 proteins, Neomycin, Sorbitol, Virus: Measles, Virus: Rubella, Chick embryo cells
Product Descriptions

MMR® II Measles, Mumps, and Rubella Virus Vaccine Live
Manufacturer Merck & Co.
Microorganism Measles, Mumps, Rubella
Licensed 12/29/2006
Recommendations M-M-R II is indicated for simultaneous immunisation against measles, mumps, and rubella in persons 12 to 15 months of age or older. A second s.c. injection of M-M-R II or monovalent measles vaccine is recommended.
Ingredients Gelatin, Neomycin, Sorbitol, Sucrose, Sodium chloride, Bovine (cow) serum, Sodium phosphate, Virus: Measles, Virus: Mumps, Virus: Rubella, Egg protein, Human albumin
Product Descriptions

MORBILVAX Live, attenuated measles vaccine
Manufacturer Biovac
Microorganism Measles
Licensed registration # 28/30.1/0054
Recommendations Two s.c. injections administered between 9 months and 18 months of age.
Ingredients Neomycin, Virus: Measles, Chick embryo cells, Kanamycin (antibiotic)
Product Descriptions http://home.intekom.com/pharm/biovac/morbilvx.html

Moru-Viraten Measles and Rubella Virus Vaccine, Live, Attenuated
Manufacturer Berna
Microorganism Measles, Rubella
Licensed discontinued 2001
Recommendations Single 0.5 mL injection administered to those 12 months of age or older.
Ingredients Virus: Measles, Virus: Rubella
Product Descriptions

Priorix® Combined measles, mumps and rubella vaccine, live, attenuated
Manufacturer GlaxoSmithKline
Microorganism measles, mumps and rubella
Licensed 11/25/1997
Recommendations Single injection at 12 months of age with booster recommended at 4-6 years of age.
Ingredients Human Diploid cells: MRC5 proteins, Sorbitol, Virus: Measles, Virus: Mumps, Virus: Rubella, Chick embryo cells, Lactose, Mannitol, Amino acids, Human albumin, Neomycin sulphate
Product Descriptions

ProQuad® Measles-Mumps-Rubella-Varicella Virus Vaccine Live, MMRV
Manufacturer Merck & Co.
Microorganism Measles, Mumps, Rubella, Varicella
Licensed 02/27/2007 – suspended production 03.22.2007
Recommendations Indicated for use in children 12 months to 12 years of age. You must wait at least 1 month between getting a regular MMR vaccine and ProQuad. ProQuad may be given at the same time as the Hib and HepB vaccines. ProQuad may be used as the first dose of MMR and Varivax. ProQuad may be used as the second dose of MMR, if the child also needs a chicken pox shot.
Ingredients Gelatin, Monosodium Glutamate (MSG), Human Diploid cells: MRC5 proteins, Neomycin, Sorbitol, Sodium bicarbonate, Sucrose, Sodium chloride, Sodium phosphate-dibasic dodecahydrate, Bovine (cow) serum, Potassium phosphate, Virus: Measles, Virus: Mumps, Virus: Rubella, Human diploid cells (WI-38), Chick embryo cells, Potassium chloride, Virus: Varicella (chickenpox), Human albumin
Product Descriptions

Rimevax Live attenuated measles vaccine (Schwarz strain)
Manufacturer SmithKline/RIT
Microorganism Measles
Licensed
Recommendations Single s.c. or i.m. injection, optimal age 15 months of age.
Ingredients Virus: Measles, Chick embryo cells, Neomycin sulphate
Product Descriptions http://home.intekom.com/pharm/smith_kb/rimevax.html

Trimovax LIVE ATTENUATED VIRUS VACCINE
Manufacturer Aventis
Microorganism Measles, mumps, rubella
Licensed
Recommendations First injection 12 months, second between 3 and 6 years.
Ingredients Virus: Measles, Virus: Mumps, Virus: Rubella, Human albumin
Product Descriptions Package insert

TRIVIRATEN BERNA Live vaccine for active immunisation against measles (Edmonston-Zagreb strain), mumps (high titre Rubini strain) and rubella (Wistar RA 27/3 strain)
Manufacturer Swiss Serum & Vaccine Institute
Microorganism Measles, mumps, rubella
Licensed
Recommendations Single subcutaneous injection of 0.5 mL, independent of age.
Ingredients Sorbitol, Virus: Measles, Virus: Mumps, Virus: Rubella, Lactose, Human albumin
Product Descriptions